Features
COVER STORY
Onerous Regulations Put ACOs on Ropes
Health insurers can be doing more to come up with creative ways to pay providers and organize care
DIGITAL | HTML
Payers Step in With ‘Real-World’ Comparative Effectiveness Research
With access to large patient populations, health plans are in a position to mine a fresh set of data, but concerns about bias remain
DIGITAL | HTML
A Conversation With Michael Kanter, MD: Casting a Wider Net
Kaiser Permanente takes on patient safety initiatives in the outpatient setting
DIGITAL | HTML
Pursuing a Bang for the Buck In the Battle of the Bulge
For health plans and employer groups, the economics of battling obesity are not always obvious
DIGITAL | HTML
Plans Breathe Life Into COPD Efforts
The disease has risen quickly to become the third-leading cause of death in the world — getting there much faster than anyone expected
DIGITAL | HTML
PEER-REVIEWED
Health Care Costs Associated With Treatment Modification in Type 2 Diabetes Mellitus Patients Taking Oral Anti-diabetic Drugs
A comparison of health care costs in patients with diabetes who do not initially respond to oral therapy suggests that it might be appropriate and clinically beneficial for providers to consider adding another oral agent, rather than up-titrating the current medication, particularly beyond intermediate dose levels
DIGITAL | HTML
Departments
EDITOR’S MEMO
Did Push for ACOs Ignore Basic Math?
DIGITAL | HTML
LEGISLATION & REGULATION
IPAB Likely to Put Pressure On Medicare Advantage and Part D
The Independent Payment Advisory Board, created by the Affordable Care Act, favors hospitals over health plans
DIGITAL | HTML
MEDICATION MANAGEMENT
E-Prescribing Grows Quickly, Suffers From Data Problems
Health plans play a key role in data quality and will benefit from improvements
DIGITAL | HTML
COMPENSATION MONITOR
Pharmacists test payment model based on outcomes
DIGITAL | HTML
THE FORMULARY FILES
Government payers shouldering more Rx payments
DIGITAL | HTML
PLAN WATCH
PBM Effort Takes Cue From Reform, Market
DIGITAL | HTML
TOMORROW’S MEDICINE
New Prostate Cancer Drug Encourages Development of Treatment Pathway
With Zytiga joining the ranks, managed care may have a way to develop an oncology strategy for a common type of cancer
DIGITAL | HTML
MANAGED CARE OUTLOOK
Medical cost trend for 2012 to hit 8.5 percent
DIGITAL | HTML
News
600K Young Adults Benefit From ACA DIGITAL | HTML
Cancer Drug Category Facing 34% to 42% Growth DIGITAL | HTML
Headlines On Deadline DIGITAL | HTML
More Primary Care, Lower Death Rate DIGITAL | HTML
Slower rates for health care costs reported by Standard and Poor’s DIGITAL | HTML

Paul Lendner ist ein praktizierender Experte im Bereich Gesundheit, Medizin und Fitness. Er schreibt bereits seit über 5 Jahren für das Managed Care Mag. Mit seinen Artikeln, die einen einzigartigen Expertenstatus nachweisen, liefert er unseren Lesern nicht nur Mehrwert, sondern auch Hilfestellung bei ihren Problemen.